Depomed (DEPO) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
CRMT, More
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q1 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $104.8 million versus the consensus estimate of $107.1 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- Freedom Broker Starts Unity Bancorp (UNTY) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
